Yervoy

0:35:43

Immunotherapy: Yervoy and Beyond

0:00:55

Yervoy Gets a New Use

0:01:34

Dr. Sharpless on Managing Toxicities With Nivolumab/Ipilimumab in Melanoma

0:02:44

Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227

0:01:55

Investigating Responses to Nivolumab and Ipilimumab in Advanced RCC

0:02:54

Combining nivolumab and ipilimumab in patients with resected stage IV melanoma

0:06:16

Treatment-free survival results of nivolumab and salvage nivolumab + ipilimumab for accRCC

0:01:57

Dr. Luke Discusses the Controversy Surrounding Ipilimumab/Nivolumab Combo in Melanoma

0:00:58

Combination Nivolumab and Ipilimumab Shows Efficacy in Advanced Melanoma

0:01:03

Dr. Long on Nivolumab/Ipilimumab in Patients with Melanoma Brain Metastases

0:03:16

Melanoma patients who discontinued nivolumab and ipilimumab experienced equal or better PFS

0:01:00

Tocilizumab with ipilimumab and nivolumab in unresectable melanoma

0:09:41

YERVOY - cancer medicine - Generic Name , Brand Names, How to use, Precautions, Side Effects etc.

0:06:21

New Long-term Data 'Clearly Favor' Combination Ipilimumab/Nivolumab in Melanoma

0:01:24

Dr. Ernstoff Discusses Nivolumab and Ipilimumab in Advanced Melanoma

0:02:04

Benefits and risks of reinduction ipilimumab/nivolumab in patients with melanoma

0:30:19

Immunotherapy With Yervoy Taking The Brakes Off The Immune System

0:01:00

PRIME-HCC: ipilimumab and nivolumab in liver cancer

0:01:11

CheckMate 8HW: nivolumab and ipilimumab in MSI-H/dMMR mCRC

0:11:48

ASCO LUNG Cancer Roundtable - NSCLC Trial Updates: CheckMate 9LA Opdivo and Yervoy with Chemo vs

0:01:17

Dr. Shoushtari on the Role of Nivolumab and Ipilimumab in Mucosal Melanoma

0:02:08

Nivolumab with ipilimumab for mRCC

0:06:01

Metastatic RCC: Using Frontline Ipilimumab/Nivolumab

0:10:02

Unresectable NSCLC - Does Checkmate 227's Suggestion of an Immunotherapy Combination of Yervoy and O